Yuhan Corp Preferred Cash Flow Conversion Efficiency

Latest as of March 2026: 0.016x

Yuhan Corp Preferred cash flow conversion efficiency. Based on the latest financial reports, Yuhan Corp Preferred (000105) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩37.15 Billion ≈ $25.18 Million USD) by net assets (₩2.34 Trillion ≈ $1.59 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Yuhan Corp Preferred (2014–2025)

Cash flow conversion efficiency of Yuhan Corp Preferred from 2014 to 2025. This chart illustrates how Yuhan Corp Preferred's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Yuhan Corp Preferred share price for real-time trading data and today's change.

Yuhan Corp Preferred Cash Flow Conversion Ratio Explained

Yuhan Corp Preferred cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Yuhan Corp Preferred Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuhan Corp Preferred ranked by their cash flow conversion efficiency. Also see 000105 stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Global Knafaim Leasing Ltd
TA:GKL
0.027x
Bintang Samudera Mandiri Lines Tbk PT
JK:BSML
0.055x
Rothwell International Co. Limited
KQ:900260
0.415x
Critical Elements Lithium Corporation
V:CRE
-0.018x
OPAL Fuels Inc
NASDAQ:OPAL
0.021x
Deswell Industries Inc
NASDAQ:DSWL
0.027x
PTL LTD Ordinary Shares
NASDAQ:PTLE
-0.445x
Bridgepoint Group Plc
LSE:BPT
0.015x

Annual Cash Flow Conversion Efficiency for Yuhan Corp Preferred (2014–2025)

The table below shows the annual cash flow conversion efficiency of Yuhan Corp Preferred from 2014 to 2025. Review Yuhan Corp Preferred free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩2.36 Trillion
≈ $1.60 Billion
₩106.23 Billion
≈ $71.99 Million
0.045x +77.12%
2024-12-31 ₩2.15 Trillion
≈ $1.46 Billion
₩54.60 Billion
≈ $37.00 Million
0.025x -60.58%
2023-12-31 ₩1.98 Trillion
≈ $1.34 Billion
₩127.75 Billion
≈ $86.58 Million
0.064x +29.92%
2022-12-31 ₩2.01 Trillion
≈ $1.36 Billion
₩99.53 Billion
≈ $67.45 Million
0.050x -3.07%
2021-12-31 ₩1.94 Trillion
≈ $1.31 Billion
₩99.00 Billion
≈ $67.09 Million
0.051x +227.54%
2020-12-31 ₩1.85 Trillion
≈ $1.25 Billion
₩28.83 Billion
≈ $19.54 Million
0.016x -60.96%
2019-12-31 ₩1.65 Trillion
≈ $1.12 Billion
₩65.99 Billion
≈ $44.72 Million
0.040x -29.32%
2018-12-31 ₩1.65 Trillion
≈ $1.12 Billion
₩93.45 Billion
≈ $63.33 Million
0.057x -27.94%
2017-12-31 ₩1.61 Trillion
≈ $1.09 Billion
₩126.13 Billion
≈ $85.47 Million
0.079x +58.48%
2016-12-31 ₩1.50 Trillion
≈ $1.01 Billion
₩74.14 Billion
≈ $50.25 Million
0.050x -46.47%
2015-12-31 ₩1.36 Trillion
≈ $924.32 Million
₩126.23 Billion
≈ $85.55 Million
0.093x +25.11%
2014-12-31 ₩1.28 Trillion
≈ $864.64 Million
₩94.39 Billion
≈ $63.96 Million
0.074x --

About Yuhan Corp Preferred

KO:000105 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$45.29 Million
₩66.83 Billion KRW
Market Cap Rank
#22106 Global
#1384 in Korea
Share Price
₩58200.00
Change (1 day)
+0.34%
52-Week Range
₩58000.00 - ₩113300.00
All Time High
₩188400.00
About

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more